The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multi-institutional prospective study to compare postoperative quality of life of patients who undergo proximal or total gastrectomy for early gastric cancer (CCOG1602).
 
Yumiko Hojo
No Relationships to Disclose
 
Mitsuro Kanda
No Relationships to Disclose
 
Yoshinari Mochizuki
No Relationships to Disclose
 
Chie Tanaka
No Relationships to Disclose
 
Seiji Ito
Honoraria - Otsuka; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst); Ono Pharmaceutical (Inst)
 
Takuya Watanabe
No Relationships to Disclose
 
Satoshi Sueoka
No Relationships to Disclose
 
Akiharu Ishiyama
No Relationships to Disclose
 
Takanobu Yamada
Honoraria - BMS; Johnson & Johnson/Janssen; Ono Pharmaceutical; Taiho Pharmaceutical
 
Takashi Oshima
No Relationships to Disclose
 
Masashi Hattori
No Relationships to Disclose
 
Shinya Koike
No Relationships to Disclose
 
Kiyoshi Ishigure
No Relationships to Disclose
 
Hitoshi Teramoto
No Relationships to Disclose
 
Kenta Murotani
No Relationships to Disclose
 
Yasuhiro Kodera
Honoraria - Abbvie; Amgen; Bristol Myers Squibb; Chugai Pharma; Covidien; Daiichi Sankyo; Edwards Lifesciences; Lilly Japan; Miyarisan Pharmaceutical; MSD K.K; Nippon Kayaku; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical; Tsumura & Co.; Yakult Honsha
Consulting or Advisory Role - Daii Sankyo
Research Funding - abbott Japan (Inst); Abbvie (Inst); Bayer (Inst); Chugai Pharma (Inst); Covidien (Inst); Daiichi Sankyo (Inst); EA Pharma (Inst); Johnson & Johnson (Inst); Kaken Pharmaceutical (Inst); Lilly Japan (Inst); Nippon Kayaku (Inst); Otsuka (Inst); Pfizer (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); TOA Pharmaceuticals (Inst); Tsumura & Co. (Inst)